跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,350 条关于
“SQ Innovation AG”
全部
9,350
临床试验
1,324
药物
521
机构
488
资讯
7,017
11个月前
SQ Innovation Secures Series B Funding Following FDA Approval of Subcutaneous Furosemide for Heart Failure
去年
SQ Innovation's Lasix ONYU Receives Tentative FDA Approval for Congestive Heart Failure Treatment
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
11个月前
FDA Approves Lasix ONYU, First At-Home Subcutaneous Furosemide Infusion Device for Heart Failure
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
去年
Made Scientific Expands Princeton Facility with 12,000 sq. ft. GMP Manufacturing Space for Commercial Cell Therapy Production
12个月前
Kindeva Opens 150,000 Sq. Ft. UK Facility to Develop Environmentally Friendly Inhaler Propellants
4年前
RESMAIN Study: Resminostat Shows Promise in Cutaneous T-Cell Lymphoma Maintenance
第 1 页,共 702 页
上一页
下一页